A research on evaluating the legal quality of pharmaceutical patents by patent characteristics

Abstract

Abstract: Some China drug patents that Pharmaceutical Multinational Corporations held could not meet the legal requirements of China Patent Law on granted patent. This paper collects Pharmaceutical Multinational Corporations' patents that have suffered invalidation application from 2001 to 2012 and discusses theoretically the patent characteristics that could significantly influence legal quality according to the characteristics of pharmaceutical industry. Then, this paper makes an empirical analysis on the influence of the patent characteristics to legal quality and establishes the regression equations by the patent characteristics and the probability ending with revocation. The empirical results show the expression of the patent characteristics on the legal quality of pharmaceutical patents is different from other industries. Five patent characteristics, including the number of claims, examples, etc., significantly influence legal quality of pharmaceutical patents. The direction and the degree of the explanatory from patent characteristics to legal quality and economic quality are different.

Key words: pharmaceutical patent, patent characteristic, invalidation application, legal quality

CLC Number:

G306

Liu Lichun, Qi Su. A research on evaluating the legal quality of pharmaceutical patents by patent characteristics[J]. Science Research Management, 2015, 36(6): 119-127.

References

[1] 陈小霞, 于大伟, 刘晓斌, 等. 中国化学药领域发明专利态势分析[J].科学观察, 2010, 5(2):37-40. Chen Xiaoxia, Yu Dawei, Liu Xiaobin, at al. Invention patent analysis of chemical drugs [J].Science Focus, 2010, 5(2):37-40. [2] Chen, W.Y. The study on the importance of patent quality to improve industrial technology from the U.S. legislation and practical experience[J]. NTPU Law Review, 2010, 74(6): 147-196. [3] Malackowski, J., Barney, J. What is patent quality? A merchant banc's perspective [J] Les Nouvelles, 2008, 123(2):123 -134. [4] Mann, R.J., Allison, J.R. Disputed quality of software patents[J]. Washington University Law Review, 2007, 85(2): 297-342. [5] 黎运智, 孟奇勋. 问题专利的产生及其控制[J]. 科学学研究, 2009, 27(5): 660-665. Li Yunzhi, Meng Qixun. The origin of questionable patent and its solutions[J]. Studies in Science of Science, 2009, 27(5):660-665. [6] Allison, J.R., Lemley, M.A. Empirical evidence on the validity of litigated patents[J]. American Intellectual Property Law Association (AIPLA) Quarterly Journal, 1998, 26(3):185. [7] 张米尔, 胡素雅, 国伟. 低质量专利的识别方法及应用研究[J]. 科研管理, 2013, 34(3): 122-127. Zhang Mier, Hu Suya, Guo Wei. Identification method for low quality patents and its applications[J]. Science Research Management, 2013, 34(3):122-127. [8] Federico, P.J. Adjudicated patents, 1948-54[J]. Journal of the Patent & Trademark Office Society, 1956, 38(4): 233, 236. [9] Koenig, G.K. Patent invalidity: A statistical and substantive analysis [M]. C. Boardman Company, 1974. [10] Harhoff, D., Reitzig, M. Determinants of opposition against EPO patent grants-The case of biotechnology and pharmaceuticals[J]. International Journal of Industrial Organization, 2004, 22(4): 443-480. [11] Merges, R.P., As many as six impossible patents before breakfast: Property rights for business concepts and patent system reform [J]. Berkeley Technology Law Journal, 1999, 14(2): 577-615. [12] Hall, B.H., Thoma, G., Torrisi, S. Financial patenting in Europe[J]. European Management Review, 2009, 6(1): 45-63. [13] Scellato, G., Calderini, M., Caviggioli, F., et al. Study on the quality of the European patent system[R]. 2011. [14] Mann, R.J., Underweiser, M. A. New look at patent quality: Relating patent prosecution to validity[J]. Journal of Empirical Legal Studies, 2012, 9(1): 1-32. [15] Lanjouw, J.O., Schankerman, M. Patent quality and research productivity: Measuring innovation with multiple indicators [J]. The Economic Journal, 2004, 114(495): 441-465. [16] Harhoff, D., Scherer, F.M., Vopel, K. Citations, family size, opposition and the value of patent rights[J]. Research Policy, 2003, 32(8): 1343-1363. [17] 万小丽.专利质量指标研究[D].华中科技大学, 2009.Wan Xiaoli. Study on indicators of patent quality[D].Huazhong University of Science and Technology, 2009. [18] Su, H.N., Chen, C.M.L., Lee, P.C. Patent litigation precaution method: Analyzing characteristics of US litigated and non-litigated patents from 1976 to 2010[J]. Scientometrics, 2012, 92(1): 181-195. [19] Bessen, J., Meurer, M.J. The patent litigation explosion[J]. Boston University School of Law Working Paper, 2005 (05-18): 10. [20] 彭司勋. 中国药学年鉴[R]. 上海: 第二军医大学出版社, 2001-2012. Peng Sixun. Chinese pharmaceutical yearbook[R].Shanghai: Second Military Medical University Press, 2001-2012. [21] Burke, P.F., Reitzig, M. Measuring patent assessment quality-Analyzing the degree and kind of (in) consistency in patent offices' decision making[J]. Research Policy, 2007, 36(9): 1404-1430. [22] 陈海秋, 韩立岩. 专利质量表征及其有效性: 中国机械工具类专利案例研究[J]. 科研管理, 2013, 34(5): 93-101.Chen Haiqiu, Han Liyan. Indicators for patent quality and their effectiveness: A case study on machine tools patents issued by SIPO [J]. Science Research Management, 2013, 34(5): 93-101. [23] 宋河发, 穆荣平, 陈芳. 专利质量及其测度方法与测度指标体系研究[J]. 科学学与科学技术管理, 2010, 31(4): 21-27.Song Hefa, Mu Rongping, Chen Fang. Study on the patent quality and it's measurement index system [J]. Science of Science and Management of Science & Technology, 2010, 31(4):21-27. [24] 刘洋, 温珂, 郭剑. 基于过程管理的中国专利质量影响因素分析[J]. 科研管理, 2012, 33(12): 104-109. Liu Yang, Wen Ke, Guo Jian. The determinants analysis on Chinese patent quality based on the process management [J]. Science Research Management, 2012, 33(12): 104-109. [25] 卞雅莉. 科学引文对企业专利质量的影响——以纳米材料产业为例[J]. 情报杂志, 2013, 32(1): 50-54.Bian Yali. The influence of science citation on the firm's patent quality-nanomaterial industry as an example [J]. Journal of Intelligence, 2013, 32(1): 50-54. [26] Hu, Y., Bian, Y., Wang, Y. Opening the black box of pharmaceutical patent value: An empirical analysis[J]. Drug Information Journal, 2008, 42(6): 561-568. [27] Guo, Y., Hu, Y., Zheng, M., et al. Patent indicators: A window to pharmaceutical market success[J]. Expert Opinion on Therapeutic Patents, 2013, 23(7): 1-7. [28] Trappey, A.J.C., Trappey, C.V., Wu, C.Y., et al. A patent quality analysis for innovative technology and product development [J]. Advanced Engineering Informatics, 2012, 26(1): 26-34. [29] Chen, Y.S., Chang, K.C. Exploring the nonlinear effects of patent citations, patent share and relative patent position on market value in the US pharmaceutical industry[J]. Technology Analysis & Strategic Management, 2010, 22(2): 153-169. [30] Tsai, C.T., Shih, H.Y., Wang, B., et al. Exploring patent quality indicators in pre-filing stage:Development of propositions and suggestion of research method[C].Technology Management for Emerging Technologies (PICMET), 2012 Proceedings of PICMET'12:IEEE, 2012: 916-922. [31] Wuchty, S., Jones, B.F., Uzzi, B. The increasing dominance of teams in production of knowledge[J]. Science, 2007, 316(5827): 1036-1039. [32] Cockburn, I.M., Kortum, S., Stern, S. Are all patent examiners equal? The impact of characteristics on patent statistics and litigation outcomes[M]. National Bureau of Economic Research, 2002. [33] Harhoff, D., Wagner, S. The duration of patent examination at the European patent office [J]. Management Science, 2009, 55(12): 1969-1984. [34] Régibeau, P., Rockett, K. Innovation cycles and learning at the patent office: Does the early patent get the delay?[J]. The Journal of Industrial Economics, 2010, 58(2): 222-246. [35] 国家知识产权局规划发展司.2001-2008年我国化学药领域发明专利态势分析[R].专利统计简报, 2009(6). The Development Planning Department of SIOP. Invention patent analysis of chemical drugs from 2001 to 2008[R]. Patent Statistics Reports, 2009(6). [36] PWC. Patent litigation study litigation continues to rise amid growing awareness of patent value[R].2012. [37] 吴明隆. 问卷统计分析实务: SPSS操作与应用[M]. 重庆: 重庆大学出版社, 2010.Wu Minglong. Statistical analysis for questionnaire: operation and use of SPSS [M]. Chongqing: Chongqing University Press, 2010.